Baculovirus Surface Display of Hemagglutinin and Neuraminidase for Monoclonal Antibody Production
Abstract
The H7N9 influenza virus that emerged in 2013 is a dangerous infectious disease with a high mortality rate of up to 40%. Developing effective monoclonal antibodies (mAbs) to detect and treat the infection of this virus is therefore critical. In this study, we expressed hemagglutinin (HA) and neuraminidase (NA) of H7N9 (A/Anhui/1/2013) on the surface of baculovirus (i.e., HA7-Bac and NA9-Bac). Our results showed that both HA or NA proteins displayed on HA7-Bac or NA9-Bac could well maintain their native biological function. Mice antisera derived from the injections of either HA7-Bac- or NA9-Bac exhibited high inhibitory activity in the hemagglutination and neuraminidase assay of H7N9 virus. mAbs generated by immunization with HA7-Bac exhibited high neutralizing activity against H7N9 virus infectivity in cell assays, whereas mAbs generated by immunization with NA9-Bac inhibited neuraminidase activity. These results proved that baculovirus display of HA and NA from H7N9 could be convenient agents to generate neutralizing mAbs against virus infection.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
P. Rijal, B. B. Wang, … K.-Y. A. Huang·bioRxiv·Jun 26, 2019
- Monoclonal antibodies targeting the influenza virus N6 neuraminidase
S. Strohmeier, F. Amanat, … F. Krammer·bioRxiv·Feb 15, 2021
- Antigenic characterisation of human monoclonal antibodies for therapeutic use against H7N9 avian influenza virus
P. Chang, D. Lukosaityte, … M. Iqbal·bioRxiv·Sep 16, 2022
- Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin
Garazi Peña Alzua, André Nicolás León, … Florian Krammer·Nature CommunicationsPeer-reviewed·Dec 13, 2025
- Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availability
Mirte N. Pascha, Marlies Ballegeer, … Cornelis A. M. de Haan·bioRxiv·Sep 3, 2024
- Mosaic display of stable hemagglutinin monomers induces broad immune responses
Hyo‐Jin Kim, Seong Cheol Min, … Kyung Hyun Kim·bioRxiv·Apr 10, 2024